Health Care Videos and Podcasts
Telehealth Flexibility: Key Regulatory Changes Impacting Providers During and Beyond the Coronavirus Pandemic
About This Video Series
Our Thought Leaders in Health Law® video series and Diagnosing Health Care podcast series examine the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
A physician group should conduct extensive “reverse due diligence” before entering into a private equity (PE) partnership.
Physician groups can keep their practice competitive–and on the “cutting edge”—by partnering with a private equity (PE) platform.
A PE partnership allows physicians access to the PE platform’s seasoned and sophisticated management team and capital.
A private equity (PE) transaction can help physicians “hedge” the uncertain future of private medical practices in an ever-changing and regulated industry.
Partnering with a private equity (PE) investor can help physicians monetize the value of their practice.
Private equity investment in physician groups has steadily grown over the last several years, leaving some groups wondering, is PE for us? There are five critical factors to consider.
$3 billion recovered under the False Claims Act. That’s what the US Department of Justice reported collecting in FY2019.
Examining how the FDA’s approach is impacting innovation and product development in the medical device industry.
The risks companies face as the restrictions on the use of medical and recreational marijuana are relaxed in an increasing number of states across the country.
Key employment law concerns that health care companies should address during a transaction.
Methods for tackling the many demands that in-house counsel face in today’s health care environment.
Why due diligence is a critical step for investors when entering into a transaction with any company interacting in the health care space.
Legal implications and concerns arising from artificial intelligence (AI) in the health care and life sciences industry.
What the ongoing shift of Medicaid funding from the federal government to the states means for health care payors and providers.
The risks FCA enforcement trends have posed for both health care companies and individuals, and ways to minimize these risks in this environment.
New business opportunities arising in 2018 as a result of changes to the government’s TRICARE program.
Legal and regulatory trends driving business opportunities in the precision medicine industry.
Examining the legal and regulatory implications of rapid change in the behavioral health care space.
How the dietary supplement industry has been impacted by recent government enforcement and regulatory trends.
Tracking the evolution of antitrust issues in the health care industry and discussing what to keep top of mind in the current environment.
Payment model changes, new regulatory approaches, and enforcement issues related to drug pricing and reimbursements.
Assessing the complex regulatory environment that digital health companies need to consider when developing an effective business strategy.
What home care organizations can do as they face increasing government scrutiny and fraud and abuse enforcement.
Understanding the government’s renewed focus on holding individual executives and members of boards of directors accountable for corporate wrongdoing.
Examining the 2016 election results from a variety of (legal, regulatory, and policy) perspectives.
Tracking the rapid rate of integration, consolidation, and collaboration in the health care industry.
Latest trends and new developments in health care investment from a variety of (legal, regulatory, and policy) perspectives.
Explore the health care industry’s shift from a fee-for-service payment system toward value-based payment in order to improve the quality of patient care and lower costs.
Best strategies to use when navigating the complex coding, coverage, and payment regulations issued by the Centers for Medicare & Medicaid Services (CMS).